Reviva pharmaceuticals holdings, inc. interview to air on bloomberg u.s. on the redchip money report®

Cupertino, calif., march 24, 2022 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph), (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), respiratory and metabolic diseases, today announced that an interview with founder, president and ceo dr. laxminarayan bhat will air on the redchip money report® on bloomberg tv, march 26, at 7 p.m. eastern time (et). bloomberg tv is available in an estimated 73 million homes across the united states.
RVPH Ratings Summary
RVPH Quant Ranking